Parexel Named “Best Contract Research Organization” at 17th Annual Vaccine Industry Excellence (ViE) Awards
04 avr. 2024 09h00 HE
|
Parexel International LLC
DURHAM, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Announces CEO Succession Plan
18 mars 2024 09h05 HE
|
Parexel International LLC
DURHAM, N.C., March 18, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Appoints Susan R. Salka to Board of Directors
01 févr. 2024 09h00 HE
|
Parexel International LLC
DURHAM, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel and Japanese Foundation for Cancer Research Announce Strategic Alliance
10 janv. 2024 08h55 HE
|
Parexel International LLC
DURHAM, N.C. and TOKYO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
Parexel Named “Best Contract Research Organization” at 19th Annual Scrip Awards
17 nov. 2023 07h30 HE
|
Parexel International LLC
DURHAM, N.C., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Named 2023 Healthcare Businesswomen’s Association ACE Award Honoree
08 nov. 2023 08h55 HE
|
Parexel International LLC
DURHAM, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Global Investigative Sites Recognize Parexel with the 2023 Society for Clinical Research Sites Eagle Award
12 oct. 2023 08h55 HE
|
Parexel International LLC
DURHAM, N.C., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel’s Amy McKee, M.D. Named to 2023 PharmaVoice 100
20 sept. 2023 08h55 HE
|
Parexel International LLC
DURHAM, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Appoints Gwyn Bebb, BM, BCh., Ph.D., to Lead Oncology Clinical Development
19 sept. 2023 08h55 HE
|
Parexel International LLC
DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development
15 août 2023 07h00 HE
|
Parexel International LLC
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets ...